US Lawsuit Over Merck & Co., Inc. (JOBS) Bone Drug Fosamax Dismissed

Bookmark and Share

Reuters -- A Manhattan federal judge has dismissed a lawsuit alleging that Merck & Co's osteoporosis drug Fosamax causes jaw damage, two months after a jury deadlock led to a mistrial in a similar case.
MORE ON THIS TOPIC